• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Novel treatment for neuroblastoma by live-attenuated poliovirus

Research Project

Project/Area Number 21K07862
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 52050:Embryonic medicine and pediatrics-related
Research InstitutionMie University

Principal Investigator

Toyoda Hidemi  三重大学, 医学系研究科, 准教授 (60525327)

Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2023: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2022: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords神経芽腫 / ポリオウイルス / 抗腫瘍免疫
Outline of Research at the Start

神経芽腫は小児固形腫瘍で最も多い悪性腫瘍で、予後は非常に不良であり、新しい治療法の開発が望まれています。これまで申請者らは、ポリオウイルス(以下PV)は神経芽腫細胞に対して強い抗腫瘍活性を持ち、マウスに移植した腫瘍が消失する事を報告してきました。さらに神経芽腫をPVで治療することで抗腫瘍免疫が誘導されることが示唆され、これらの知見をもとにした第I相臨床試験を三重大学医学部附属病院で行っています。今回申請者は、臨床応用できる安全な弱毒PVの開発を行うとともに、PV治療にて誘導される抗腫瘍免疫を増強させるため併用療法の開発を行います。

Outline of Final Research Achievements

We have previously reported that poliovirus (PV) has strong antitumor activity against neuroblastoma cells. The neuroblastoma cell line used in our study was a mouse neuroblastoma cell line with high CD155 expression. Transplantation of a mouse neuroblastoma cell line without CD155 expression into mice that had acquired antitumor immunity did not result in tumor formation, confirming that CD155 is not a target molecule for antitumor immunity. The study also demonstrated that CD8 T cells are important in the anti-tumor immunity obtained by treating neuroblastoma with PV.

Academic Significance and Societal Importance of the Research Achievements

研究代表者は、PVにより細胞死を誘導された腫瘍細胞は、抗腫瘍免疫を誘導することを証明し、CD8T細胞が抗腫瘍免疫に重要な役割を果たしていることを証明した。このことから、PVで細胞死を誘導した腫瘍細胞を、がんワクチンとして使用できる。さらに抗腫瘍免疫を誘導する原因タンパクが同定できれば、その遺伝子のコードするタンパクをがんワクチンの抗原として使用でき、またその抗原を標的としたCAR-T細胞療法の応用につながる。さらに、PVは神経芽腫だけでなく脳腫瘍を初めとする他の固形腫瘍にも細胞死を誘導することが知られており、これらの難治性小児がんの治療への臨床応用が可能となる。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (13 results)

All 2023 2022 2021

All Journal Article (10 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 8 results,  Open Access: 6 results) Presentation (3 results) (of which Int'l Joint Research: 1 results,  Invited: 2 results)

  • [Journal Article] Secondary malignancy after carbon ion radiotherapy in a 15‐year‐old female with Ewing sarcoma2023

    • Author(s)
      Ushida Eri、Toyoda Hidemi、Hanaki Ryo、Amano Keishiro、Okamoto Masahiko、Yamada Seiji、Nojima Takayuki、Hirayama Masahiro
    • Journal Title

      Pediatric Blood & Cancer

      Volume: 70 Issue: 12

    • DOI

      10.1002/pbc.30676

    • Related Report
      2023 Annual Research Report
  • [Journal Article] Case report: Thyroid storm in a three-year-old girl presenting with febrile status epilepticus and hypoglycemia2023

    • Author(s)
      Aoki Yusuke、Hanaki Ryo、Toyoda Hidemi、Emori Koichi、Miyahara Masazumi、Hirayama Masahiro
    • Journal Title

      Frontiers in Pediatrics

      Volume: 11

    • DOI

      10.3389/fped.2023.1213040

    • Related Report
      2023 Annual Research Report
  • [Journal Article] Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia2023

    • Author(s)
      Miyagawa Naoyuki、Goto Hiroaki、Ogawa Atsushi、Kikuta Atsushi、Kosaka Yoshiyuki、Sekimizu Masahiro、Tomizawa Daisuke、Toyoda Hidemi、Hiramatsu Hidefumi、Hara Junichi、Mochizuki Shinji、Nakayama Hideki、Yoshimura Kenichi、Iijima-Yamashita Yuka、Sanada Masashi、Ogawa Chitose
    • Journal Title

      International Journal of Hematology

      Volume: - Issue: 2 Pages: 267-276

    • DOI

      10.1007/s12185-023-03609-8

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Improved Antitumor Effect of NK Cells Activated by Neutrophils in a Bone Marrow Transplant Model2023

    • Author(s)
      Nakato Daisuke、Iwamoto Shotaro、Amano Keishiro、Ito Takahiro、Toyoda Hidemi、Hanaki Ryo、Morimoto Mari、Niwa Kaori、Tawara Isao、Imanaka-Yoshida Kyoko、Ogawa Masahiro、Hirayama Masahiro
    • Journal Title

      Mediators of Inflammation

      Volume: 2023 Pages: 1-9

    • DOI

      10.1155/2023/6316581

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Successful hematopoietic stem cell transplantation for two patients with relapse of intrachromosomal amplification of chromosome 21-positive B-cell precursor acute lymphoblastic leukemia2022

    • Author(s)
      Harada Tomoya、Toyoda Hidemi、Tsuboya Naoki、Hanaki Ryo、Amano Keishiro、Hirayama Masahiro
    • Journal Title

      Frontiers in Pediatrics

      Volume: 10 Pages: 01-05

    • DOI

      10.3389/fped.2022.960126

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Autonomic Nervous System in Preterm Very Low Birth Weight Neonates with Intraventricular Hemorrhage2022

    • Author(s)
      Shiono Ai、Bonno Motoki、Toyoda Hidemi、Ogawa Masahiro、Tanaka Shigeki、Hirayama Masahiro
    • Journal Title

      American Journal of Perinatology

      Volume: 2022 Issue: S 01 Pages: 1-7

    • DOI

      10.1055/a-1926-0335

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Nafamostat mesylate prevents metastasis and dissemination of neuroblastoma through vascular endothelial growth factor inhibition2022

    • Author(s)
      Morimoto Mari、Toyoda Hidemi、Niwa Kaori、Hanaki Ryo、Okuda Taro、Nakato Daisuke、Amano Keishiro、Iwamoto Shotaro、Hirayama Masahiro
    • Journal Title

      Molecular and Clinical Oncology

      Volume: 17 Issue: 3 Pages: 1-5

    • DOI

      10.3892/mco.2022.2571

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models2022

    • Author(s)
      Tanaka Kuniaki、Kato Itaru、Dobashi Yuu、Imai Jun‐ichi、Mikami Takashi、Kubota Hirohito、Ueno Hiroo、Ito Mamoru、Ogawa Seishi、Nakahata Tatsutoshi、Takita Junko、Toyoda Hidemi、Ogawa Chitose、Adachi Souichi、Watanabe Shinya、Goto Hiroaki
    • Journal Title

      Cancer Science

      Volume: 113 Issue: 11 Pages: 3814-3825

    • DOI

      10.1111/cas.15506

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation2021

    • Author(s)
      Hanaki Ryo、Toyoda Hidemi、Iwamoto Shotaro、Morimoto Mari、Nakato Daisuke、Ito Takahiro、Niwa Kaori、Amano Keishiro、Hashizume Ryotaro、Tawara Isao、Hirayama Masahiro
    • Journal Title

      Immunity, Inflammation and Disease

      Volume: 9 Issue: 4 Pages: 1489-1499

    • DOI

      10.1002/iid3.503

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Primary cytomegalovirus infection during pregnancy and congenital infection: a population-based, mother?child, prospective cohort study2021

    • Author(s)
      Shimada Kyoko、Toriyabe Kuniaki、Kitamura Asa、Morikawa Fumihiro、Minematsu Toshio、Ikejiri Makoto、Suga Shigeru、Toyoda Hidemi、Amano Keishiro、Kitano Masako、Usui Satoko、Masuda Sawako、Ikeda Tomoaki
    • Journal Title

      Journal of Perinatology

      Volume: 41 Issue: 10 Pages: 2474-2481

    • DOI

      10.1038/s41372-021-01157-9

    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Presentation] 再発難治性ALLに対する治療戦略2023

    • Author(s)
      豊田秀実
    • Organizer
      第126回日本小児科学会学術集会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] Experience of an international study for treatment of standard risk childhood relapsed acute lymphoblastic leukemia (IntReALL SR 2010) in Japan2023

    • Author(s)
      Hidemi Toyoda
    • Organizer
      日本血液学会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies2022

    • Author(s)
      Arend von Stackelberg, Jean-Pierre Bourquin, Martin Zimmermann, Tamas Revesz, Andishe Attarbaschi, Alina Ferster, Lucie Sramkova, Thomas Leth Frandsen, Paivi Maria Lahteenmaki, Ronit Elhasid, Hidemi Toyoda
    • Organizer
      American Society of Hematology
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi